Australian Business GrantsFinder
Open

R&D Tax Incentive - Clinical Trials Determination

Funding
Varies
Region
Commonwealth
View Official Page

Overview

A tax incentive program that deems clinical trial activities as core R&D activities, simplifying application and providing certainty for companies conducting clinical trials. Companies can claim tax benefits on eligible clinical trial expenses when registered with the program.

Eligibility Requirements

Clinical trials must be registered with the TGA (Therapeutic Goods Administration) and have a valid CTA (Clinical Trial Authorisation) or CTN (Clinical Trial Notification) number. All core R&D activities must occur solely in Australia for AOF applications. Activities must be conducted for the purpose of generating new knowledge with outcomes that cannot be known in advance.

Who Can Apply

SmeLarge Business

Relevant Industries

HealthPharmaceutical

How to Apply

Applications are submitted through the official government portal. Review the eligibility criteria carefully before applying, and ensure all supporting documents are prepared.

Visit the official application page
Disclaimer: Grant information is sourced from official government websites and updated regularly. Always verify current eligibility and deadlines on the official program page before applying.

Related Grants

Open·Commonwealth·$25,000,000

MRFF 2022 Frontier Health and Medical Research Grant Opportunity

This grant program supports researchers pursuing innovative projects to develop new products and interventions in health and medical research, with the goal of creating treatments for serious and incurable health conditions. Funding supports programs of research comprising linked projects with a 10-year time horizon, from proof-of-concept through to full clinical implementation.

Open·Commonwealth·Up to $2,000,000

MRFF – Traumatic Brain Injury Mission – 2026

This grant supports medical research and medical innovation projects aimed at improving outcomes for Australians with traumatic brain injury (TBI). Two streams are available: Stream 1 focuses on testing novel treatments and interventions for moderate to severe TBI, while Stream 2 supports research on implementing clinical guidelines and protocols for mild TBI with attention to equity and access across diverse populations.

Open·Commonwealth·$500,000 - $4,000,000

2026 NHMRC-European Partnership for Brain Health

The 2026 NHMRC-European Partnership for Brain Health (EP BrainHealth) Grant Opportunity supports Australian participation and collaboration in transnational research projects through European Partnership for Brain Health (EP BrainHealth) Call for Proposals. The EP BrainHealth offers 2 calls: one in the field of neurological, mental disorders and sensory disorders (EP BrainHealth Call 1) and one in the field of neurodegenerative disorders (EP BrainHealth Call 2). Further information on the EP BrainHealth Call for Proposals is available from the EP BrainHealth website. Eligibility: Applications will only be accepted from NHMRC approved Administering Institutions. • Australia-based researchers must submit an application at the full proposal stage to both NHMRC and the EP BrainHealth Secretariat to be considered for 2026 NHMRC-EP BrainHealth funding. A copy of the full proposal as submitted to EP BrainHealth must be included in the 2026 NHMRC-EP BrainHealth application for funding. • The C